Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
860 participants
INTERVENTIONAL
2008-10-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fluid Management for Cesarean Section III
NCT00973414
Fluid Management for Cesarean Section
NCT00488111
Fluid Volume-hypotension Association in Cesarean Under Neuraxial Anesthesia
NCT01013090
Perineuraxial Anesthesia Fluid Management and Infant Neurobehaviors
NCT00987701
Effects of Crystal Solution and Colloid Solution on Mother and Fetus
NCT04432675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prior crystalloid
Crystalloid (Ringer's Lactate) was given before spinal anesthesia
Ringer's Lactate
Ringer's Lactate 8 ml/kg was given intravenously before or after spinal anesthesia in cesarean section
Posterior crystalloid
Crystalloid (Ringer's Lactate) was given after spinal anesthesia
Ringer's Lactate
Ringer's Lactate 8 ml/kg was given intravenously before or after spinal anesthesia in cesarean section
Prior colloid
Colloid (6% hydroxyethyl starch) was given before spinal anesthesia
Six percent hydroxyethyl starch
Hydroxyethyl starch (6%) was given before or after spinal anesthesia in cesarean section
Posterior colloid
Colloid (6% hydroxyethyl starch) was given after spinal anesthesia
Six percent hydroxyethyl starch
Hydroxyethyl starch (6%) was given before or after spinal anesthesia in cesarean section
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ringer's Lactate
Ringer's Lactate 8 ml/kg was given intravenously before or after spinal anesthesia in cesarean section
Six percent hydroxyethyl starch
Hydroxyethyl starch (6%) was given before or after spinal anesthesia in cesarean section
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First time of delivery
* ASA status I-II
* No premature
* No genetic and infectious diseases
* Chinese
Exclusion Criteria
* \> 40 yr
* Subjects with cardiac and pulmonary disorders
* Dislocation of placenta
* Pregnant hypertension
* Allergy to local anesthetics
* Unwilling to cooperation
* Need intraoperative administration of vascular active agents
* With significant delivery side effects
21 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing Maternity and Child Health Care Hospital
OTHER
Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nanjing Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
XiaoFeng Shen, MD
Role: STUDY_CHAIR
Nanjing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Affiliated Nanjing Maternity and Child Health Care Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NJMU-08711MZ
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.